Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 5,131 | 4,520 | 4,020 | 3,793 | 3,957 |
| Operating Income | -5,131 | -4,520 | -4,020 | -3,793 | -3,957 |
| Other Income | 134 | 172 | 72 | 97 | 145 |
| Pre-tax Income | -4,998 | -4,348 | -3,948 | -3,696 | -3,812 |
| Net Income Continuous | -4,998 | -4,348 | -3,948 | -3,696 | -3,812 |
| Net Income | $-4,998 | $-4,348 | $-3,948 | $-3,696 | $-3,812 |
| EPS Basic Total Ops | -1.77 | 4.69 | -6.71 | -6.28 | -6.50 |
| EPS Basic Continuous Ops | -1.77 | 4.70 | -6.71 | -6.28 | -6.50 |
| EPS Diluted Total Ops | -1.77 | 4.69 | -6.71 | -6.28 | -6.50 |
| EPS Diluted Continuous Ops | -1.77 | 4.70 | -6.71 | -6.28 | -6.50 |
| EPS Diluted Before Non-Recurring Items | N/A | -14.80 | -6.71 | -6.28 | -6.50 |
| EBITDA(a) | $-5,106 | $-4,495 | $-3,995 | $-3,768 | $-3,932 |